iiinova — where your digital self keeps evolving

Lloyd Czaplewski @lloydcz.bsky.social · 03/02/2026

Persica Pharmaceuticals’ Phase 1b #Modic Trial results have been published in @eClinicalMedicine – Read the paper here: doi.org/10.1016/j.ec... #BackPain #Modic🧪💊

010

Lloyd Czaplewski @lloydcz.bsky.social · 30/01/2026

An overview of global public and philanthropic investments into antibacterial therapeutics (2017–23) - The Lancet Microbe lnkd.in/efsNRCKM 🧪 Using the Global AMR R&D Hub's Dynamic Dashboard, to review antibacterial funding. Provided great insights that complement scientific project reviews.

thelancet.com

An overview of global public and philanthropic investments into antibacterial therapeutics (2017–23)

Antibacterial research and development (R&D) increasingly relies on public and philanthropic investments over private investments and on academia and small businesses over large pharmaceutical compani...

021

Reposted by Lloyd Czaplewski

Dan Jagger @auditorynerves.bsky.social · 30/03/2025

Millions of people worldwide with severe lower back pain may get relief from a new drug that uses antibiotics rather than painkillers to tackle the condition. Small trial suggests injected drug PP353 could be ‘a gamechanger’, but experts express scepticism. 🧪💉💊🤸🏼‍♀️ www.theguardian.com/society/2025...

theguardian.com

New drug for lower back pain could be ‘a gamechanger’

Exclusive: early stage trials of drug that uses antibiotics finds benefits for people whose pain is caused by infection

3212

Lloyd Czaplewski @lloydcz.bsky.social · 05/03/2025

Congratulations to everyone involved in the project including colleagues at Persica, our wide network of partners, the clinical team and especially the patients. lnkd.in/e-FcHD5b 🧪

061

Reposted by Lloyd Czaplewski

Global AMR R&D Hub @globalamrhub.bsky.social · 20/01/2025

Exciting News! The Global AMR R&D Hub is now on #Bluesky! 🌟 We're expanding our presence to connect with even more #stakeholders, #researchers, and thought leaders to mitigate the impact of #AMR! 🚨 Stay tuned and follow us!

031

Lloyd Czaplewski @lloydcz.bsky.social · 20/12/2024

Persica Pharmaceuticals Ltd The last patient has now completed the 12-month follow-up in our groundbreaking #Modic Trial. T If you’d like to learn more about the trial: lnkd.in/gwB_7Bmx Results are expected in Q1 2025. 🧪

020

Lloyd Czaplewski @lloydcz.bsky.social · 02/12/2024

Reposting this now that I have joined the Science feed! 🧪 #MRI #Scicomm #SciNews

020

Lloyd Czaplewski @lloydcz.bsky.social · 23/11/2024

Developing a novel treatment for chronic low back pain To learn more persicapharmaceuticals.com/persica-news/ Or read Hagger et al. doi.org/10.1002/jsp2... Tripathi et al. doi.org/10.1002/jsp2... #WAAW #WAAW2024 #clbp #BackPain #Modic

010

Reposted by Lloyd Czaplewski

Layla Moran MP 🔶🕊️ @laylamoran.bsky.social · 21/11/2024

Good news. We need to support the courts without fear or favour. Remember these were linked to warrants for Hamas leaders too who have since been killed. No one should be above the courts and we just respect the process.

721556

Reposted by Lloyd Czaplewski

Dr Julia Grace Patterson @jujuliagrace.bsky.social · 20/11/2024

Hello! If you oppose NHS privatisation please could you repost this and follow me? I need to know who to follow next (it’ll be you!) ⭐️💙

14469497

Lloyd Czaplewski @lloydcz.bsky.social · 19/11/2024

Two papers, summarising ten-years of R&D to devise a new treatment for chronic low back pain. Thanks to everyone involved, and especially the patients in the clinical trial. To learn more lnkd.in/e98AQA4Q onlinelibrary.wiley.com/doi/full/10.... onlinelibrary.wiley.com/doi/full/10....

000